{"id":"https://openalex.org/W2065656409","doi":"https://doi.org/10.1080/02713680902919532","title":"Ocular Pharmacokinetics of AzaSite Xtra\u20142% Azithromycin Formulated in a DuraSite Delivery System","display_name":"Ocular Pharmacokinetics of AzaSite Xtra\u20142% Azithromycin Formulated in a DuraSite Delivery System","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2065656409","doi":"https://doi.org/10.1080/02713680902919532","mag":"2065656409","pmid":"https://pubmed.ncbi.nlm.nih.gov/19899983"},"language":"en","primary_location":{"id":"doi:10.1080/02713680902919532","doi":"https://doi.org/10.1080/02713680902919532","is_oa":false,"landing_page_url":"https://doi.org/10.1080/02713680902919532","pdf_url":null,"source":{"id":"https://openalex.org/S74941265","display_name":"Current Eye Research","issn_l":"0271-3683","issn":["0271-3683","1460-2202"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Eye Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2065656409"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Erwin C. Si","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erwin C. Si","raw_affiliation_strings":["Department of Preclinical Research, InSite Vision, Alameda, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Preclinical Research, InSite Vision, Alameda, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070710559","display_name":"Paul S. Cheung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul S. Cheung","raw_affiliation_strings":["Department of Preclinical Research, InSite Vision, Alameda, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Preclinical Research, InSite Vision, Alameda, California, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111627775","display_name":"Lyle M. Bowman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lyle Bowman","raw_affiliation_strings":["Department of Development/Operations, InSite Vision, Alameda, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Development/Operations, InSite Vision, Alameda, California, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Kamran Hosseini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kamran Hosseini","raw_affiliation_strings":["Department Clinical Affairs, InSite Vision, Alameda, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department Clinical Affairs, InSite Vision, Alameda, California, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2737,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.786224,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"34","issue":"6","first_page":"485","last_page":"491"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azithromycin","display_name":"azithromycin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ocular-pharmacokinetics","display_name":"ocular pharmacokinetics","score":0.9300000071525574},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.6579999923706055},{"id":"https://openalex.org/keywords/bacterial-conjunctivitis","display_name":"bacterial conjunctivitis","score":0.9290000200271606},{"id":"https://openalex.org/keywords/pharmacokinetics-pharmacodynamics","display_name":"pharmacokinetics/pharmacodynamics","score":0.7260000109672546},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8220000267028809},{"id":"https://openalex.org/keywords/macrolide-antibiotics","display_name":"macrolide antibiotics","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2778907293","wikidata":"https://www.wikidata.org/wiki/Q165399","display_name":"Azithromycin","level":3,"score":0.9764717817306519},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8277695178985596},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6103917956352234},{"id":"https://openalex.org/C2776882836","wikidata":"https://www.wikidata.org/wiki/Q168291","display_name":"Cornea","level":2,"score":0.5929203033447266},{"id":"https://openalex.org/C2775984611","wikidata":"https://www.wikidata.org/wiki/Q273554","display_name":"Conjunctiva","level":2,"score":0.5534906387329102},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5160588622093201},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.49781131744384766},{"id":"https://openalex.org/C2908692415","wikidata":"https://www.wikidata.org/wiki/Q167844","display_name":"Bacterial Conjunctivitis","level":3,"score":0.4424005150794983},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43033531308174133},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.29563963413238525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21661439538002014},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19837355613708496},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.16960352659225464},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13976863026618958}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003234","descriptor_name":"Conjunctivitis, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017963","descriptor_name":"Azithromycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017963","descriptor_name":"Azithromycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/02713680902919532","doi":"https://doi.org/10.1080/02713680902919532","is_oa":false,"landing_page_url":"https://doi.org/10.1080/02713680902919532","pdf_url":null,"source":{"id":"https://openalex.org/S74941265","display_name":"Current Eye Research","issn_l":"0271-3683","issn":["0271-3683","1460-2202"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Eye Research","raw_type":"journal-article"},{"id":"pmid:19899983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19899983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current eye research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W12110163","https://openalex.org/W1176927102","https://openalex.org/W1197842251","https://openalex.org/W1968954857","https://openalex.org/W1990022466","https://openalex.org/W2000814575","https://openalex.org/W2026395354","https://openalex.org/W2027266089","https://openalex.org/W2035781500","https://openalex.org/W2050582522","https://openalex.org/W2051023323","https://openalex.org/W2054013913","https://openalex.org/W2057639869","https://openalex.org/W2057725023","https://openalex.org/W2071110455","https://openalex.org/W2093337868","https://openalex.org/W2096595821","https://openalex.org/W2107369068","https://openalex.org/W2124188111","https://openalex.org/W2134412546","https://openalex.org/W2148942014","https://openalex.org/W2162348589","https://openalex.org/W2162398839","https://openalex.org/W2165852564","https://openalex.org/W2430315520","https://openalex.org/W4391756744","https://openalex.org/W4406056424"],"related_works":["https://openalex.org/W2035781500","https://openalex.org/W2064275382","https://openalex.org/W1508765356","https://openalex.org/W227014840","https://openalex.org/W942460756","https://openalex.org/W1600199661","https://openalex.org/W2163308108","https://openalex.org/W1981835654","https://openalex.org/W1993499252","https://openalex.org/W2965392149"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,55,96],"pharmacokinetics":[2],"of":[3,8,37,52,63,72,88,99],"a":[4,23,49],"2%":[5,53,100],"ocular":[6,75],"solution":[7],"azithromycin":[9,38,64,101],"in":[10,14,41],"DuraSite":[11],"was":[12],"evaluated":[13],"rabbits":[15],"to":[16],"determine":[17],"whether":[18],"the":[19,70,79,83],"PK/PD":[20,97],"parameters":[21],"support":[22],"once-a-day":[24],"for":[25,82,114],"three-day":[26],"therapeutic":[27],"regimen":[28],"against":[29,104],"bacterial":[30,89],"conjunctivitis.":[31],"MATERIALS":[32],"AND":[33],"METHODS:":[34],"Mean":[35],"levels":[36,56],"were":[39,57],"determined":[40,58],"tears,":[42],"bulbar":[43],"conjunctiva,":[44],"cornea,":[45],"and":[46],"plasma":[47],"following":[48],"single":[50],"drop":[51],"azithromycin.":[54],"by":[59,91],"HPLC-MS.":[60],"RESULTS:":[61],"Concentrations":[62],"peaked":[65],"at":[66,92],"30":[67],"minutes.":[68],"At":[69],"end":[71],"24":[73],"hours,":[74],"tissue":[76],"concentrations":[77],"exceeded":[78],"MIC":[80],"breakpoint":[81],"most":[84],"common":[85,105],"causative":[86,106],"pathogens":[87],"conjunctivitis":[90],"least":[93],"7-fold.":[94],"CONCLUSION:":[95],"profile":[98],"suggests":[102],"efficacy":[103],"bacteria":[107],"with":[108],"just":[109],"one":[110],"dose":[111],"per":[112],"day":[113],"three":[115],"days.":[116]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2065656409","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
